High density lipoprotein as prognostic indicator in patient with diabetic foot
DOI:
https://doi.org/10.18203/2320-6012.ijrms20201906Keywords:
Diabetic foot, High density lipoprotein, Prognostic indicatorAbstract
Background: Diabetic is a chronic metabolic disease with vascular disorder and HDL (High Density Lipoprotein) is a vascular protector acting agent. One of the most difficult complication of diabetics are diabetic foot with often lead to an amputation due to vascular disorder. Objective of this study aims to determine the relationship of HDL levels with diabetic foot severity by comparing HDL levels in each diabetic foot grade according to the Wagner classification.
Methods: This is a cross sectional study, with new inpatient and outpatient with diabetic foot ulcer that never received therapy in Wahidin Sudirohusodo Hospital as a study population in April 2018 to June 2018 time period. Frequency distribution, Spearman’s Correlation, Anova, and Chi Square statistical analytic was done with p <0.05 considered as significant.
Results: HDL level was wound highest in Grade I and lowest in Grade IV and V. HDL level comparison according to Wagner comparison shows significant difference, p<0.001.
Conclusions: There were a negative correlation as an analysis results shows between HDL level and Wagner classification, whereas the lower HDL level, the higher diabetic foot grade and HDL can be used as a prognosis predictor and planning therapy.
References
Ahmeti I, Bogoev M, Petrovski G, Milenkovic T, Krstevska B, Taravari A. Influence of metabolic dysregulation in pre ulcerative phase of diabetic foot. J Diabetic Foot Complic. 2012;4(1):6-12.
Pei E, Li J, Lu C, Xu J, Tang T, Ye M, et al. Effects of lipids and lipoproteins on diabetic foot in people with type 2 diabetes mellitus: A meta-analysis. J Diabetes Complic. 2014 Jul 1;28(4):559-64.
Jain AK, Joshi S. Diabetic foot classifications: Review of literature. Med Sci. 2013 Mar;2(3):715-21.
Kartono T, Mallapasi N, Mulawardi, Laiding S, Aminyoto M, Prihantono. Correlation of HDL cholesterol serum and Wagner severity level of diabetic foot ulcer. Int J Res Medi Sci. 2017;5(12):5129-34.
[5] Manda V, Sreedharan J, Muttappallymyalil J, et al. Foot ulcers and risk factors among diabetic patients visiting Surgery Departement in a University Teaching Hospital in Ajman, UAE. Int J Medi Pub. 2012; 3 : 34-37
Soelistijo SA, Zufry H. Konsensus Pengendalian dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. 2011:6-10.
Fauci A, Braunwald E, Kasper D. Diabetes Mellitus. Harrison’s Manual Medi. 2009;17:942-7.
Singh S, Pai DR, Yuhhui C. Diabetic foot ulcer-diagnosis and management. Clin Res Foot Ankle. 2013 Nov 7;1(3):120.
Mendes JJ, Neves J. Diabetic foot infections: current diagnosis and treatment. J Diabetic Foot Complic. 2012:26-45.
Lüscher TF, Landmesser U, von Eckardstein A, Fogelman AM. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circulat Res. 2014 Jan 3;114(1):171-82.
